Clinical Trials on Nausea and Vomiting in Pediatric Age Group in Hong Kong

Total 14 results

The University of Hong Kong
Tung Wah Group of Hospitals

Completed

Programme Evaluation on Effectiveness of The Use of Movement-based x 'Elderspirituality - Fu Le Mun Sum' Intervention to Support Elderly People With Depressive Symptoms

Depression in Old Age

Hong Kong
The University of Hong Kong

Recruiting

High-definition Transcranial Direct Current Stimulation (HD-tDCS) in Late-life Depression (LLD)

Depression in Old Age

Hong Kong
Chinese University of Hong Kong
Abbott

Recruiting

RCT of Combination Effect of Vibration Treatment and HMB Supplementation on Myosteatosis and NMJ Degeneration

Sarcopenia | Musculoskeletal Abnormalities | Connective Tissue Diseases in Old Age

Hong Kong
Chinese University of Hong Kong

Recruiting

Localized Analysis of Normalized Distance From Scalp to Cortex and Personalized Evaluation (LANDSCAPE) (LANDSCAPE)

Parkinson Disease | Aging | Dementia Alzheimers | Depression in Old Age | Dementia Frontotemporal

Hong Kong
GlaxoSmithKline

Completed

Post-Operative Nausea And Vomiting Study In Female Patients

Postoperative Nausea and Vomiting | Nausea and Vomiting, Postoperative

United States, Spain, Philippines, Israel, Hong Kong, Thailand, United Kingdom, Hungary, Slovenia, Norway, Denmark
GlaxoSmithKline

Completed

Casopitant And ZOFRAN To Prevent Post Operative Nausea And Vomiting In Women

Postoperative Nausea and Vomiting | Nausea and Vomiting, Postoperative

Spain, United States, Philippines, Belgium, Hong Kong, Canada, Germany, Czech Republic, Thailand, Pakistan, Russian Federation
GlaxoSmithKline

Completed

Study for The Prevention Of Nausea in Cancer Patients Receiving Highly Emetogenic Cisplatin Based Chemotherapy

Nausea and Vomiting | Chemotherapy-Induced

Taiwan, Belgium, Singapore, Netherlands, Mexico, Slovakia, Italy, Philippines, Austria, Chile, Romania, Poland, Czech Republic, Hungary, Pakistan, Croatia, Peru, Argentina, Hong Kong
GlaxoSmithKline

Completed

Casopitant (Oral) And ZOFRAN To Prevent Postoperative Nausea And Vomiting In Women

Nausea and Vomiting, Postoperative

United States, Hong Kong, Ireland, France, Philippines, Germany, Hungary, Thailand, Canada, Pakistan, United Kingdom
The University of The West Indies

Completed

The Effect of Ginger on the Incidence of Postoperative Nausea and Vomiting

Postoperative Nausea and Vomiting

Jamaica
GlaxoSmithKline

Completed

Study Of Prevention of Chemo-Induced Nausea and Vomiting Caused By Moderately Emetogenic Chemotherapy

Chemotherapy-Induced Nausea and Vomiting | Nausea and Vomiting, Chemotherapy-Induced

Taiwan, United States, Germany, Russian Federation, Spain, Ireland, Thailand, Hong Kong, Mexico, Philippines, Austria, Chile, Greece, Poland, Canada, Czech Republic, United Kingdom, Hungary, Pakistan, Slovakia, Singapore, Portugal, ... and more
University of South Florida
National Cancer Institute (NCI)

Completed

Acupressure in Controlling Nausea in Young Patients Receiving Highly Emetogenic Chemotherapy (SCUSF1202)

Unspecified Childhood Solid Tumor, Protocol Specific | Chemotherapy-induced Nausea and Vomiting | Central Nervous System Tumor, Pediatric

United States, Canada
GlaxoSmithKline

Completed

Intravenous And Oral Casopitant (GW679769) For The Prevention Of Chemotherapy Induced Nausea And Vomiting

Nausea | Vomiting | Nausea and Vomiting, Chemotherapy-Induced

United States, Germany, Bulgaria, Hungary, Philippines, Russian Federation, Taiwan, Korea, Republic of, Belgium, Denmark, Hong Kong, Slovakia, South Africa, Spain, Ireland, Latvia, Thailand, Italy, United Kingdom, Argentina, Aus... and more
Helsinn Healthcare SA
The Physicians' Services Incorporated Foundation; George Clinical Pty Ltd

Completed

A Study to Assess the Safety and the Efficacy of IV Fosnetupitant/Palonosetron (260 mg/0.25 mg) Combination Compared to Oral Netupitant/Palonosetron (300 mg/0.5 mg) Combination for the Prevention of CINV in AC Chemotherapy in Women With Breast Cancer

Chemotherapy-induced Nausea and Vomiting

United States, Georgia
Forest Laboratories
Ironwood Pharmaceuticals, Inc.

Completed

A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 6-17 Years Who Fulfill Modified Rome III Criteria for Child/Adolescent Functional Constipation (FC)

Functional Constipation in Children Ages 6-17 Years

United States, Canada

Clinical Trials on Nausea and Vomiting in Pediatric Age Group in Hong Kong

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Luxembourg

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations